Results 91 to 100 of about 560,406 (374)

Editorial: Methods in radiation oncology. [PDF]

open access: yesFront Oncol
Kefayat A   +3 more
europepmc   +2 more sources

ACR Accreditation for Utah Valley Hospital’s Radiation Oncology Center

open access: yes, 2019
Becoming an accredited clinic through the American College of Radiology (ACR) and their Radiation Oncology Practice Accreditation (ROPA) program will provide third-party evaluation of patient care to ensure the best treatment possible for patients.
Manigold, Remy
core  

A call for the aggressive treatment of oligometastatic and oligo-recurrent non-small cell lung cancer. [PDF]

open access: yes, 2012
Metastatic non-small cell lung cancer (NSCLC) carries a dismal prognosis. Clinical evidence suggests the existence of an intermediate, or oligometastatic, state when metastases are limited in number and/or location.
Niibe, Yuzuru   +4 more
core   +3 more sources

Understanding and measuring mechanical signals in the tumor stroma

open access: yesFEBS Open Bio, EarlyView.
This review discusses cancer‐associated fibroblast subtypes and their functions, particularly in relation to extracellular matrix production, as well as the development of 3D models to study tumor stroma mechanics in vitro. Several quantitative techniques to measure tissue mechanical properties are also described, to emphasize the diagnostic and ...
Fàtima de la Jara Ortiz   +3 more
wiley   +1 more source

The landscape of digital resources in radiation oncology

open access: yesTechnical Innovations & Patient Support in Radiation Oncology, 2022
In recent years, the number of educational medical resources accessible to residents and practicing radiation oncologists online has grown exponentially to include discussion boards, wikis, videos, podcasts, journal clubs, online communities, and ...
Matthew M. Culbert   +2 more
doaj  

Radiation Oncology: Today and Tomorrow [PDF]

open access: yesFrontiers in Oncology, 2011
The twentieth century witnessed the birth of the medical discipline of Radiation Oncology, beginning with the discovery and clinical application of radium in the early 1900s. Subsequently, clinical radiation oncology evolved as a major modality for the treatment of most solid cancers with the initial use of orthovoltage x-rays, to the use of ...
openaire   +3 more sources

Establishment and biological characterization of radioresistant colorectal cancer cell lines

open access: yesFEBS Open Bio, Volume 15, Issue 6, Page 1009-1021, June 2025.
Under ionizing radiation exposure, radiation‐sensitive cancer cells exhibit oxidative stress and DNA damage, while radiation‐resistant cancer cells exhibit strong antioxidant properties and DNA damage repair. Radiotherapy resistance is a major cause of recurrence and metastasis in colorectal cancer (CRC).
Tian‐Yin Qu   +10 more
wiley   +1 more source

Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer [PDF]

open access: yesarXiv, 2017
Quantitative extraction of high-dimensional mineable data from medical images is a process known as radiomics. Radiomics is foreseen as an essential prognostic tool for cancer risk assessment and the quantification of intratumoural heterogeneity. In this work, 1615 radiomic features (quantifying tumour image intensity, shape, texture) extracted from ...
arxiv  

Correction to: ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial

open access: yesRadiation Oncology, 2018
Following publication of the original article [1], the authors reported that one of the authors’ names is spelled incorrectly. In this Correction the incorrect and correct author name are shown. The original publication of this article has been corrected.
Thomas Zilli   +12 more
doaj   +1 more source

Adenosine A3 receptor antagonists as anti‐tumor treatment in human prostate cancer: an in vitro study

open access: yesFEBS Open Bio, EarlyView.
The A3 adenosine receptors (A3ARs) are overexpressed in prostate cancer. AR 292 and AR 357, as A3AR antagonists, are capable of blocking proliferation, modulating the expression of drug transporter genes involved in chemoresistance, ferroptosis, and the hypoxia response, and inducing cell death.
Maria Beatrice Morelli   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy